At the sacrifice time, overexpression of KMT2B resulted in a more than threefold increase in tumour weight compared to the control group (.11 ± .07 g vs.  .34 ± .20 g, p < .05, Figure 3B,C). This evidence concerns the gene KMT2B and neoplasm.